Unité de Fabrication des Médicaments S.A (BVMT: UMED)
Health Care · Pharmaceuticals · TN
DT8.77
-0.34% today · +5.8% 1Y
Unité de Fabrication des Médicaments S.A (BVMT: UMED) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $93.89M.
Over the last twelve months the share price has gained 5.8%, trading between 7.90 and 11.00.
Tweenvest scores Unité de Fabrication des Médicaments S.A across four factors: quality 74/100, value 56/100, growth 27/100, dividend 100/100. Its strongest factor is dividend.
UMED price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $93.89M
- Revenue (TTM)
- $51.87M
- P/E
- 15.09
- EPS
- 0.58
- Dividend yield
- 6.50%
- Beta (5Y)
- 0.17
- 52-week high
- DT11.00
- 52-week low
- DT7.90
- Avg volume (3M)
- —
- Shares outstanding
- 32.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SAMSUNG PHARM. Co., LTD.KOSE: A001360 | $96.33M | ₩1,376.00 | -3.98% |
| Fusen Pharmaceutical Company LimitedSEHK: 1652 | $95.62M | HK$1.02 | +9.73% |
| Pak Fah Yeow International LimitedSEHK: 239 | $94.91M | HK$2.39 | -2.45% |
| Merdury Biopharmaceutical CorporationTPEX: 6932 | $94.16M | NT$7.04 | +15.22% |
| PT Merck TbkIDX: MERK | $93.89M | Rp3,750.00 | -1.06% |
| AlzeCure Pharma AB (publ)OM: ALZCUR | $93.23M | Skr6.80 | +0.59% |
| Rani Therapeutics Holdings, Inc.NasdaqGM: RANI | $92.22M | $0.80 | +0.88% |
| Stella Pharma CorporationTSE: 4888 | $92.15M | ¥394.00 | -7.51% |
Figures last refreshed Oct 11, 2026.